Vadivarhe Speciality Chemicals Limited (NSE:VSCL)
20.40
+0.90 (4.62%)
At close: Oct 1, 2026
NSE:VSCL Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 457.8 | 379.05 | 400.75 | 436.79 | 214.49 |
Other Revenue | 5.7 | 2.42 | 4.47 | 6.64 | 3.29 |
| 463.5 | 381.47 | 405.23 | 443.42 | 217.78 | |
Revenue Growth | 21.50% | -5.86% | -8.61% | 103.61% | -18.31% |
Cost of Revenue | 290.19 | 291.88 | 231.83 | 275.36 | 165.49 |
Gross Profit | 173.32 | 89.59 | 173.4 | 168.06 | 52.29 |
Selling, General & Admin | 53.4 | 57.56 | 45.87 | 44.44 | 43.63 |
Other Operating Expenses | 107.74 | 92.84 | 83.6 | 87.46 | 75.39 |
Operating Expenses | 179.62 | 168.88 | 146.82 | 149.79 | 136.93 |
Operating Income | -6.31 | -79.29 | 26.58 | 18.27 | -84.64 |
Interest Expense | -13.54 | -13.6 | -13.36 | -14.77 | -15.96 |
Interest & Investment Income | 0.32 | 0.27 | 0.43 | 0.6 | 0.79 |
Currency Exchange Gain (Loss) | 0.62 | 0.81 | 1.6 | 1.27 | 1.33 |
EBT Excluding Unusual Items | -18.91 | -91.81 | 15.25 | 5.38 | -98.48 |
Gain (Loss) on Sale of Assets | -0.69 | -1.42 | -0.19 | -0.17 | -0.1 |
Other Unusual Items | 3.22 | 0.57 | - | 3.73 | 2.5 |
Pretax Income | -16.38 | -92.65 | 15.07 | 11.47 | -96.08 |
Income Tax Expense | - | - | 14.45 | - | - |
Net Income | -16.38 | -92.65 | 0.62 | 11.47 | -96.08 |
Net Income to Common | -16.38 | -92.65 | 0.62 | 11.47 | -96.08 |
Net Income Growth | - | - | -94.64% | - | - |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 13 |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 |
Shares Change | - | - | - | - | - |
EPS (Basic) | -1.28 | -7.25 | 0.05 | 0.90 | -7.52 |
EPS (Diluted) | -1.28 | -7.25 | 0.05 | 0.90 | -8.00 |
EPS Growth | - | - | -94.64% | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 56.44 | -85.52 | 13.55 | -11.08 | 3.37 |
Free Cash Flow Per Share | 4.42 | -6.69 | 1.06 | -0.87 | 0.26 |
Gross Margin | 37.39% | 23.48% | 42.79% | 37.90% | 24.01% |
Operating Margin | -1.36% | -20.79% | 6.56% | 4.12% | -38.86% |
Profit Margin | -3.53% | -24.29% | 0.15% | 2.59% | -44.12% |
Free Cash Flow Margin | 12.18% | -22.42% | 3.35% | -2.50% | 1.55% |
EBITDA | 12.18 | -60.81 | 43.92 | 35.96 | -66.95 |
EBITDA Margin | 2.63% | -15.94% | 10.84% | 8.11% | -30.74% |
D&A For EBITDA | 18.48 | 18.47 | 17.34 | 17.69 | 17.69 |
EBIT | -6.31 | -79.29 | 26.58 | 18.27 | -84.64 |
EBIT Margin | -1.36% | -20.78% | 6.56% | 4.12% | -38.86% |
Effective Tax Rate | - | - | 95.92% | - | - |
Revenue as Reported | 464.06 | 381.75 | 405.66 | 444.03 | 218.62 |
Advertising Expenses | 0.06 | 0.38 | 0.03 | 0.17 | 0.03 |